Biomarin Pharmaceutical Return on Assets:
-8.57% for March 31, 2013Biomarin Pharmaceutical Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -8.57% |
| Dec. 31, 2012 | -7.83% |
| Sept. 30, 2012 | -6.29% |
| June 30, 2012 | -7.48% |
| March 31, 2012 | -5.70% |
| Dec. 31, 2011 | -4.20% |
| Sept. 30, 2011 | -3.10% |
| June 30, 2011 | 16.21% |
| March 31, 2011 | 17.50% |
| Dec. 31, 2010 | 19.14% |
| Sept. 30, 2010 | 22.35% |
| June 30, 2010 | 1.31% |
| March 31, 2010 | 1.54% |
| Dec. 31, 2009 | -0.06% |
| Sept. 30, 2009 | 2.20% |
| June 30, 2009 | 1.55% |
| March 31, 2009 | 1.84% |
| Dec. 31, 2008 | 3.62% |
| Sept. 30, 2008 | 1.07% |
| June 30, 2008 | 0.35% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
BMRN Return on Assets Benchmarks
| Companies | |
|---|---|
| Array BioPharma | -37.10% |
| Alkermes | -2.89% |
| Cytokinetics | -58.48% |
BMRN Return on Assets Rankings
| Overall |
47th percentile 3969 of 7593 |
| Sector |
55th percentile 290 of 650 in Healthcare |
| Industry |
78th percentile 51 of 237 in Biotechnology |
BMRN Return on Assets Range, Past 5 Years
| Minimum | -8.57% | Mar 2013 |
| Maximum | 22.35% | Sep 2010 |
| Average | 2.27% |
BMRN News
BioMarin Announces BMN-673 Data in Breast and Ovarian Cancers to be Released at ASCO
GlobeNewswire May 16
GlobeNewswire May 16
